Most patients suffering from Rheumatoid Arthritis (RA) are treated with commonly prescribed medications like methotrexate , leflunomide, hydroxychloroquine, and sulfasalazine, (DMRD’s). These medications have been used to help to slow the progression of rheumatoid arthritis and save the joints and other tissues from permanent damage.
Hyperbaric oxygen therapy (HBOT) has also been experimentally demonstrated to similarly help RA patients reduce disease progression and provide beneficial outcomes.
Researchers in this study showed that adding HBOT to standard DRMD medications for RA patients were able to:
-
-
- Reduce disease activity
- Improve histopathological outcomes
- Be a far more cost-effective and lower-risk treatment option
-
“Overall, these findings highlight the potential benefits of integrating DMARD and HBOT in the management of RA” <view study>